Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Orchid Pharma Ltd

Orchid Pharma Ltd share price and stock overview

Orchid Pharma Ltd (NSE: ORCHPHARMA, BSE: 524372) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE191A01027 and a face value of Rs 10. As of 12 August 2026, it trades at Rs (1,078.55) with a market capitalisation of Rs 10260.55 crore. Figures are live and subject to change.

Orchid Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
1,078.55 -0.60 (-0.06%) downArrowC
As on: 12-Aug-2026 , 01:41 AM
Market Cap(₹Cr) 10260.55
Book Value(₹Cr) 148.4426658
BSE Code : 524372 NSE Symbol : ORCHPHARMA EPS(TTM) : 5.43 ISIN Demat : INE191A01027 P/E(TTM) : 198.27 Face Value(₹) : 10 Div & Yield % : 0

Today Market

Stock Performance

Today Market

Today's High

78,509.77

Todday's Low

78,048.26

Open at

78,509.77

Previous Close

78,542.44

Volumes

Avg Price

-388.19

Historical Performance

News

29 Jul 26
Orchid Pharma to hold board meeting
Orchid Pharma will hold a meeting of the Board of Directors of the Company on 1 August 2026.
08 Jul 26
Orchid Pharma soars on Exblifep commercialization deal in Russia
Exblifep (cefepime/enmetazobactam), a novel combination antibiotic for the treatment of complicated urinary tract infections (cUTI) and hospital-acquired and ventilator-associated bacterial pneumonia (HAP/VAP) caused by Gram-negative bacterial pathogens, subject to regulatory approval by the Ministry of Health of the Russian Federation.
07 Jul 26
Orchid Pharma and Pharmasyntez sign licensing and supply agreement for Exblifep'
Orchid Pharma (Orchid) and Pharmasyntez JSC (Pharmasyntez) have entered into a licensing and supply agreement for Exblifep' (cefepime/enmetazobactam), a novel combination antibiotic for the treatment of complicated urinary tract infections (cUTI) and hospital-acquired and ventilator-associated bacterial pneumonia (HAP/VAP) caused by Gram negative bacterial pathogens, subject to regulatory approval by the Ministry of Health of the Russian Federation.
26 May 26
Orchid Pharma rises after Q4 net profit increases 7% to Rs 24 crore
Revenue from operations rose marginally to Rs 237.61 crore in Q4 FY26 as against Rs 237.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
11-08-26 1100.00 1133.00 1070.00 1078.55 188232 16236 208922293.10 24471.70
10-08-26 1055.00 1089.90 994.00 1079.15 222143 15662 235463730.80 24583.80
07-08-26 1003.10 1010.00 989.15 1001.85 26620 3042 26610622.20 24570.65
06-08-26 998.95 1015.65 985.10 997.55 49403 6501 49303772.00 24636.00
05-08-26 1017.80 1035.00 982.10 990.35 79427 7866 80159262.55 24624.65
04-08-26 987.70 1020.00 983.40 1006.40 23659 2350 23594976.40 24614.90
03-08-26 990.00 998.00 975.10 990.65 44068 5374 43577752.70 24774.30
31-07-26 995.20 1004.95 983.20 986.55 29849 3485 29598962.00 24383.60
30-07-26 1004.00 1009.00 982.25 1000.25 36314 4097 36205003.95 24317.15
29-07-26 982.10 1022.00 982.10 1001.45 47133 6560 47378592.65 24250.20
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

10260.55

PE Ratio

198.27

PB Ratio

7.25

Dividend Yield

0

ROE

3.32

ROCE

3.61

Book Value (₹)

148.4426658

Face Value (₹)

10

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 35419957 69.84 35419957 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 35419957 69.84 35419957 1
Total ShareHolding for Promoter & Group 35419957 69.84 35419957 1
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 32440 0.06 32440 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 408009 0.80 408009 25
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 2396 0.00 2396 1
Insurance Companies 33877 0.07 33877 3
Mutual Funds / UTI 10107812 19.93 10107812 10
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 347550 0.69 347550 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10932084 21.55 10932084 48
plus  Non Institution
Bodies Corporate 801579 1.58 798341 360
Clearing Members 217 0.00 217 3
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 228180 0.45 228180 611
Foreign Non Institution Other 68 0.00 68 1
Hindu Undivided Families 158650 0.31 158650 948
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 509869 1.01 509869 16
Individuals holding nominal share capital up to Rs. 1 lakh 2640879 5.21 2640609 31440
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 26987 0.05 26987 2
Others 635 0.00 635 3
Sub Total 4367064 8.61 4363556 33384
Total Public Shareholding 15299148 30.16 15295640 33432
Total of Promoter & Public ShareHolding 50719105 100.00 50715597 33433
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 50719105 100.00 50715597 33433

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Net Sales921.93819.37665.90559.56450.06
OPM (%)10.3711.222.41-10.17-21.16
OP95.5691.9516.04-56.90-95.25
Other Income27.4730.8619.439.0015.21
PBIDT144.65141.54142.2662.1465.00
INTEREST14.5416.3532.2332.0151.34
PBDT130.11125.18110.0330.1313.67
PBT95.5691.9594.46-56.90-95.25
EO0.000.0039.210.000.00
PBT after EO95.5691.9555.25-56.90-95.25
TAXES-0.19-3.120.000.000.00
PAT99.6692.1746.32-1.95-116.53
EPS19.6519.0611.35-0.48-28.55
Raw Material63.5064.4860.9860.8754.57
Power and Fuel7.057.689.209.438.73
Employee Cost9.378.509.8111.3114.91
Other Manufacturing Expenses0.000.000.000.000.00
Selling and Administration Expenses5.946.495.257.498.14
Miscellaneous Expenses1.310.711.041.550.99
Revenue (Growth %) 12.5223.0519.0024.33-6.97
PBIDT (Growth %)2.20-0.51128.94-4.4124.06
PAT (Growth %) 8.1398.99-2,473.84-98.33-11.09
PBIDT (Margin %)15.6917.2721.3611.1014.44
PAT (Margin %) 10.8111.256.96-0.35-25.89

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Share Capital 50.7250.7240.8240.8240.8240.82
Reserves Total 1204.771099.04622.59568.58571.96688.45
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money68.5668.5668.5668.5668.5668.56
Total Shareholders Funds1324.051218.32731.97677.96681.34797.83
Secured Loans 42.6014.05222.59170.63366.84491.92
Unsecured Loans 132.01120.91108.7597.3285.9074.47
Total Debt174.61134.96331.34267.95452.74566.39
Other Liabilities3.393.6312.6011.0111.5411.79
Total Liabilities1502.051356.911075.91956.921145.621376.01
APPLICATION OF FUNDS :
Gross Block 1328.111297.021220.451176.261175.971246.98
Less : Accumulated Depreciation 714.87680.59647.39592.60505.58389.12
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 613.24616.43573.06583.66670.39857.86
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress43.9224.4646.099.787.4325.61
Producing Properties0.000.000.000.000.000.00
Investments 69.3569.4050.1249.0115.430.34
Current Assets, Loans & Advances
Inventories 326.37264.23228.74172.66150.57140.78
Sundry Debtors 241.83189.37211.91160.23131.9666.38
Cash and Bank Balance164.28257.2322.344.2118.97172.32
Loans and Advances 53.9071.4730.8145.99225.73185.29
Total Current Assets786.39782.29493.79383.08527.23564.77
Less : Current Liabilities and Provisions
Current Liabilities 192.17193.21140.64131.0472.1067.51
Provisions 2.372.083.493.013.523.25
Total Current Liabilities & Provisions194.54195.30144.12134.0575.6270.76
Net Current Assets591.85587.00349.67249.03451.61494.01
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets122.56110.8186.1182.83149.34197.50
Deferred Tax Liability122.56110.8189.3386.06152.57200.72
Net Deferred Tax0.000.00-3.22-3.23-3.23-3.22
Other Assets183.6959.6260.2068.674.001.41
Total Assets1502.051356.911075.92956.921145.631376.01
Contingent Liabilities453.5249.1738.1642.8845.120.00

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Financing Activities -164.99-216.8031.17167.0725.44
Investing Activities 67.21112.93-26.70-315.81-37.35
Net Cash Flow -73.42-14.3017.86-18.0115.58
Operating Activities 24.3689.5713.39130.7327.48

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
RGA
R G Agarwal
Chairman(Non Exe)&Dir(Non-Ind)
Executive
Functional Directors
MD
Manish Dhanuka
Executive Director & MD
Exec.
MD
Mridul Dhanuka
E D & Wholetime Director
Dir.
Independent Directors
AD
Arjun Dhanuka
Non-Exec & Non-Independent Dir
Ind.
DV
Dharam Vir
Independent Non Exe. Director
Ind.
MG
Manoj Goyal
Independent Non Exe. Director
Ind.
TS
Tanu Singla
Independent Non Exe. Director
Ind.
SS
Shubha Singh
Independent Non Exe. Director
Ind.
Other Officials
KD
Kapil Dayya
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Orchid Pharma Ltd? −

Orchid Pharma Ltd trades on NSE under ORCHPHARMA and on BSE under code 524372. The ISIN is INE191A01027 and the face value is Rs 10.

What is the share price of Orchid Pharma Ltd today? +

As of 12 August 2026, Orchid Pharma Ltd trades at Rs 1,078.55, a change of -0.60 (-0.06%) on the day. Prices are live and subject to change.

What is the market capitalisation of Orchid Pharma Ltd? +

As of 12 August 2026, Orchid Pharma Ltd has a market cap of about Rs 10260.55 crore. This figure is live and moves with the share price.

Is Orchid Pharma Ltd profitable? +

In March 2025, Orchid Pharma Ltd reported a profit after tax of Rs 99.66 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Orchid Pharma Ltd? +

: As of 12 August 2026, the PE (TTM) for Orchid Pharma Ltd is 198.27 and the price-to-book ratio is 7.25. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Orchid Pharma Ltd pay a dividend? +

As of 12 August 2026, the dividend yield for Orchid Pharma Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Orchid Pharma Ltd? +

As of the latest disclosed pattern, promoters hold 69.84% of Orchid Pharma Ltd. Public shareholding is 30.16%, including mutual funds at 19.93% and foreign institutional investors at 0.80%.

What were the latest annual financials of Orchid Pharma Ltd? +

In March 2025, Orchid Pharma Ltd reported net sales of Rs 921.93 crore, revenue growth of 12.52%, and earnings per share of Rs 19.65.
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
View Careers
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web